Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 1.00 |
| ▸ | NR3C1 | P04150 | 1/20 | 1.00 |
| ▸ | ADRB2 | P07550 | 1/20 | 1.00 |
| ▸ | HTR2C | P28335 | 1/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 1/20 | 1.00 |
| ▸ | PTGS2 | P35354 | 1/20 | 1.00 |
| ▸ | TST | Q16762 | 2/20 | 0.83 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.83 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.83 |
| ▸ | MEN1 | O00255 | 7/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.74 |
| ▸ | USP2 | O75604 | 4/20 | 0.74 |
| ▸ | HTT | P42858 | 4/20 | 0.74 |
| ▸ | HAT1 | O14929 | 4/20 | 0.74 |
| ▸ | RBBP7 | Q16576 | 4/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.74 |
| ▸ | RECQL | P46063 | 3/20 | 0.74 |
| ▸ | CASP7 | P55210 | 3/20 | 0.74 |
| ▸ | MAPT | P10636 | 3/20 | 0.74 |
| ▸ | CASP1 | P29466 | 2/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Riboflavin 5'-Phosphate SCHEMBL190079 | 1.00 | ESR1 (1.00) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| Riboflavin 5'-Phosphate SCHEMBL41133 | 1.00 | ESR1 (1.00) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| Riboflavin 5'-Phosphate SCHEMBL297863 | 1.00 | ESR1 (1.00) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| Riboflavin 5'-Phosphate SCHEMBL6681480 | 0.99 | ESR1 (0.98) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| Riboflavin 5'-Phosphate SCHEMBL29592831 | 0.96 | ESR1 (0.93) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| SCHEMBL14571231 | 0.94 | ESR1 (0.89) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| SCHEMBL19864293 | 0.94 | ESR1 (0.88) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| SCHEMBL11995383 | 0.94 | ESR1 (0.88) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| SCHEMBL3402467 | 0.93 | ESR1 (0.86) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| Riboflavin 5'-Phosphate SCHEMBL8656633 | 0.92 | TST (0.98) | ESR1NR3C1ADRB2HTR2CADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230148252-A1 | PROCESS FOR TREATING KERATIN MATERIALS USING A FLAVIN DERIVATIVE, A POLYMERIZABLE MOLECULE AND LIGHT RADIATION | L'OREAL (FR) | 2023-05-11 | — | — | US | claimed |
| EP-3727318-B1 | PROCESS FOR TREATING KERATIN MATERIALS USING A FLAVIN DERIVATIVE, A POLYMERIZABLE MOLECULE AND LIGHT RADIATION | OREAL (FR) | 2022-01-19 | — | — | EP | claimed |
| CN-113164483-A | Pharmaceutical composition for preventing or treating cancer comprising PLK1 activation inhibitor as active ingredient | 国立癌症中心 | 2021-07-23 | — | — | CN | claimed |
| US-20200375866-A1 | HAIR TREATMENT PROCESS USING A FLAVIN DERIVATIVE AND LIGHT RADIATION | L'OREAL (FR) | 2020-12-03 | — | — | US | claimed |
| CN-121628874-B | EC riboflavin kinase mutant and application thereof | 深圳希吉亚生物技术有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-12312605-B2 | Riboflavin derivative-containing medium | AJINOMOTO CO., INC. (JP) | 2025-05-27 | — | — | US | disclosed |
| US-12215263-B2 | Tracer composition | CHELSEA TECHNOLOGIES LTD (GB) | 2025-02-04 | — | — | US | disclosed |
| EP-3947598-B1 | TRACER COMPOSITION | CHELSEA TECH LTD (GB) | 2024-03-06 | — | — | EP | disclosed |
| CN-117100856-A | Application of photosensitive compound in preparation of product taking TRPA1 optical channel as target point | 广州医科大学 | 2023-11-24 | — | — | CN | disclosed |
| CN-116120585-B | Preparation method for preparing amino acid photocatalytic decarboxylation oxidation product by means of photocatalyst | 北京化工大学 | 2023-11-14 | — | — | CN | disclosed |
| US-20230174889-A1 | WATER-MISCIBLE FUNCTIONAL FLUID, UNDILUTED STOCK OF WATER-MISCIBLE FUNCTIONAL FLUID, STERILIZER FOR WATER-MISCIBLE FUNCTIONAL FLUID, AND METHOD OF STERILIZING WATER-MISCIBLE FUNCTION FLUID | YUSHIRO CHEMICAL INDUSTRY CO., LTD. (JP) | 2023-06-08 | — | — | US | disclosed |
| US-20230174889-A1 | WATER-MISCIBLE FUNCTIONAL FLUID, UNDILUTED STOCK OF WATER-MISCIBLE FUNCTIONAL FLUID, STERILIZER FOR WATER-MISCIBLE FUNCTIONAL FLUID, AND METHOD OF STERILIZING WATER-MISCIBLE FUNCTION FLUID | YUSHIRO CHEMICAL INDUSTRY CO., LTD. (JP) | 2023-06-08 | — | — | US | disclosed |
| US-7927613-B2 | Pharmaceutical co-crystal compositions | UNIVERSITY OF SOUTH FLORIDA (US) | 2011-04-19 | — | — | US | disclosed |
| EP-2292585-A1 | Screening for solid forms by ultrasound crystallization and cocrystallization using ultrasound | APTUIT (KANSAS CITY), LLC (US) | 2011-03-09 | — | — | EP | disclosed |
| US-20110014239-A1 | Preparation of Vaccines Using Photosensitizer and Light | CARIDIANBCT BIOTECHNOLOGIES, LLC (US) | 2011-01-20 | — | — | US | disclosed |
| EP-2233494-A1 | Riboswitches, methods for their use, and compositions for use with riboswitches | Yale University (US) | 2010-09-29 | — | — | EP | disclosed |
| US-7790905-B2 | Pharmaceutical propylene glycol solvate compositions | MCNEIL-PPC, INC. (US) | 2010-09-07 | — | — | US | disclosed |
| US-20070212379-A1 | Preparation of Vaccines Using Photosensitizers and Light | NAVIGANT BIOTECHNOLOGIES INC. (US) | 2007-09-13 | — | — | US | disclosed |
| US-20070134520-A1 | METHOD AND APPARATUS OF GENERATING ELECTRIC POWER | EBARA CORPORATION (JP) | 2007-06-14 | — | — | US | disclosed |
| US-20070134520-A1 | METHOD AND APPARATUS OF GENERATING ELECTRIC POWER | EBARA CORPORATION (JP) | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12215263-B2 | Tracer composition | TMEM14C, RAB5IF, S100A10 | ESR1 1731/4885NR3C1 4358/4885ADRB2 1637/4885 |
| US-20070212379-A1 | Preparation of Vaccines Using Photosensitizers and Light | PPOX, TTPA, CD47 | ESR1 4261/4885NR3C1 4583/4885ADRB2 4855/4885 |
| US-20230148252-A1 | PROCESS FOR TREATING KERATIN MATERIALS USING A FLAVIN DERIVATIVE, A POLYMERIZABLE MOLECULE AND LIGHT RADIATION | KRT18, FLNA, VIM | ESR1 4200/4885NR3C1 4719/4885ADRB2 4545/4885 |
| US-20110014239-A1 | Preparation of Vaccines Using Photosensitizer and Light | PPOX, CD47, TTPA | ESR1 4273/4885NR3C1 4627/4885ADRB2 4855/4885 |
| US-20200375866-A1 | HAIR TREATMENT PROCESS USING A FLAVIN DERIVATIVE AND LIGHT RADIATION | FH, BLVRB, NQO1 | ESR1 4399/4885NR3C1 2058/4885ADRB2 3310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.